Monday, August 24, 2026
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Work with this data → vianewsagency.com
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· January 21, 2026

3 Medical Info Systems Stocks to Gain From Digitization Despite Industry Woes

View original at finance.yahoo.com
3 Medical Info Systems Stocks to Gain From Digitization Despite Industry Woes The Medical Info Systems industry continues to expand rapidly, driven by innovations in healthcare resource management, patient data handling and integrated digital care delivery…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • 79% of health systems reported increasing their investments in digital health solutions over the past two years

    80% confidence
  • Medical Info Systems industry carries Zacks Industry Rank #161, placing it in bottom 34% of 244 Zacks industries, indicating dull near-term prospects

    80% confidence
  • Top 50% of Zacks-ranked industries outperform bottom 50% by a factor of more than 2 to 1

    80% confidence
  • Global Smart Healthcare Products market was valued at $280.48 billion in 2024 and is expected to reach $796.36 billion by 2032, at a CAGR of 15.37%

    80% confidence
  • Doximity has 95% subscription-based revenue model with strong net revenue retention

    80% confidence
  • Doximity is expanding across a $18.55 billion total addressable market

    80% confidence
  • The use of AI in healthcare market is expected to witness a CAGR of 38.6% during 2025-2030, propelled by growing demand for enhanced diagnostic accuracy, optimized workflows and personalized medicine

    80% confidence
  • Omnicell's revenues expected to witness 2.8% CAGR during 2025-2027

    80% confidence
  • In 2025, ransomware and cyberattacks rose sharply, increasingly targeting healthcare organizations and service partners, disrupting operations and exposing patient data

    80% confidence
  • Doximity covers over 80% of U.S. doctors and 60% of advanced practitioners

    80% confidence

Cited in these Via News reports